Physician profile
Lidia Starr
NPI 1851766273
$3,064.07
in general payments reported to CMS, 2019-2025
21 companies · $559 in 2025
The $559 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $474 · 2022: $210 · 2023: $660 · 2024: $1,160 · 2025: $559.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,295 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,294.77 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $534.60 | 2021-2025 | |
| Janssen Biotech, INC. | $496.81 | 2022-2024 | Tremfya, Simponi, Simponi Aria |
| Arcutis Biotherapeutics, INC. | $366.27 | 2024-2025 | Zoryve |
| Dermavant Sciences, INC. | $260.82 | 2024 | Vtama |
| Galderma Laboratories, L.P. | $226.21 | 2021-2025 | Nemluvio, Aklief |
| Amgen INC. | $154.53 | 2023 | Otezla |
| Organon LLC | $127.18 | 2025 | Vtama |
| Stemline Therapeutics INC. | $126.90 | 2021 | |
| Journey Medical Corporation | $126.71 | 2021 | |
| Almirall LLC | $123.44 | 2023 | Klisyri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $123.20 | 2022-2024 | Spevigo |
| Verrica Pharmaceuticals INC. | $115.86 | 2023 | Ycanth |
| Merz North America, INC. | $79.14 | 2021 | |
| Pfizer INC. | $51.62 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $39.92 | 2021-2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $22.87 | 2022 | |
| Incyte Corporation | $18.35 | 2023 | Opzelura |
| Biofrontera INC. | $18.24 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.02 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $17.08 | 2022 | |
| Allergan, INC. | $16.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lidia Starr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.